This Project is not specific to Greece. For more details, please visit OpenAIRE Explore.
Link with research outputs.
Please log in first and try again.
AD-resilience
FunderFrench National Research Agency (ANR)
Funder Contribution €439,687.00
DurationFrom 15 Feb 2022
Project codeANR-21-CE17-0058
Open Access mandatePublications: NoResearch data: No
Identifiers
Description
A promising path for developing precision medicine in age-related diseases is to take into account the role of disease resistance mechanisms (resilience) in addition to that of disease drivers and risk factors. AD-resilience will accelerate the development of precision medicine for patients that face Alzheimer's disease thanks to an innovative approach that is based on rich data and precision machine-learning to account for the role of resilience over pathobiology, enabling prognosis and facilitating therapeutic innovation.
Partners (5)
Start a new DMP in Loading
A promising path for developing precision medicine in age-related diseases is to take into account the role of disease resistance mechanisms (resilience) in addition to that of disease drivers and risk factors. AD-resilience will accelerate the development of precision medicine for patients that face Alzheimer's disease thanks to an innovative approach that is based on rich data and precision machine-learning to account for the role of resilience over pathobiology, enabling prognosis and facilitating therapeutic innovation.
